Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 747 across all filing types
Latest filing 2023-12-29 Regulatory Filings
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the closure of the trading window pursuant to insider trading regulations. It mentions the upcoming financial results for the third quarter ended 31st December 2023 but does not contain any financial data or results itself. The document is an announcement related to compliance and trading restrictions rather than a financial report or detailed filing. It is also under 5,000 characters and serves as a regulatory communication. Therefore, it fits best under Regulatory Filings (RNS).
2023-12-29 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Listing Compliance Department of stock exchanges, informing about the issuance of duplicate share certificates due to loss of original certificates. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate issuance and related compliance. The content is about a share certificate issuance event, not a financial report, management change, or voting result. It is a regulatory compliance notification related to share certificates, which fits best under Regulatory Filings (RNS) as it does not match other specific categories like Share Issue/Capital Change (SHA) which typically involves new shares or capital restructuring, not duplicate certificates. The document is short and formal, with no financial data or report attached.
2023-11-25 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of a conference call held on November 10, 2023, discussing the financial performance for the quarter and half year ended September 30, 2023. It includes detailed management commentary on revenue, segment performance, business outlook, and Q&A with analysts. The text explicitly states it is a transcript of the earnings conference call, which is a typical format for Call Transcripts (CT). The document is about 15,000 characters long, contains substantive discussion of financial results, and is not merely an announcement or a presentation. Therefore, the appropriate classification is Call Transcript (CT).
2023-11-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the audio recording of an analysts/investors conference call about the company's financial results for the quarter and half year ended September 30, 2023. It references the conference call and provides a link to the audio recording, but does not contain the transcript or detailed financial data itself. The document is short (1496 characters) and serves as an announcement of the availability of the call recording rather than the call transcript itself. According to the rules, announcements about conference calls or their recordings are not classified as Call Transcripts (CT) but rather as Regulatory Filings (RNS) since it does not contain the full transcript or substantive financial data.
2023-11-10 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled 'Investor Presentation' and is explicitly described as an investor presentation for the second quarter and half year ended 30th September 2023. It contains detailed company overview, strategic focus, financial highlights, historical performance, management team, manufacturing facilities, R&D focus, and other business-related information. The document is lengthy (15,000 characters) and contains substantive content typical of an investor presentation. It is not a brief announcement or a certification letter, nor is it a full annual or quarterly report with detailed financial statements. Therefore, the document fits the definition of an Investor Presentation (IP).
2023-11-09 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated November 9, 2023, announcing the financial results for the second quarter and half year ended September 30, 2023. It contains detailed financial performance data including revenue, EBITDA, PAT, segmental performance, and management commentary on operational performance and outlook. The document is not a full annual or interim report but a summary announcement of quarterly financial results with key highlights and management comments. It is not a transcript, audit report, or regulatory filing. The length (9909 characters) and content indicate it is a financial results announcement, which corresponds to an Earnings Release (ER).
2023-11-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.